| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.10B | -8.1% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥0.02B | — |
| Net income | ¥0.02B | -23.1% |
| Gross margin | 35.3% | Net margin 19.5% |
| Revenue Q/Q | -13.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.06B | 64.7% |
| R&D | ¥0.01B | 7.1% |
| SG&A | ¥0.01B | 7.4% |
| Tax & other | ¥0.00B | 2.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
五洲医疗 ・ 华康洁净 ・ 和顺科技 ・ 瑞泰新材 ・ 普瑞眼科 ・ 宏源药业 ・ 杰创智能 ・ 威尔高 ・ 同星科技 ・ 通力科技 ・ 华融化学 ・ 普蕊斯
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies